Twist Bioscience Corporation (NASDAQ: TWST) and Biotia has launched today the next-generation SARS-CoV-2 assay for the surveillance of COVID-19. The new highly sensitive nucleic acid hybridization capture-based assay is created to discover all nucleic acid sequences of SARS-CoV-2. This new assay also gives the
